JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209159200 on March 19, 2003

J. Biol. Chem., Vol. 278, Issue 21, 18930-18937, May 23, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/21/18930    most recent
M209159200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokuda, H.
Right arrow Articles by Kozawa, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokuda, H.
Right arrow Articles by Kozawa, O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Incadronate Amplifies Prostaglandin F2{alpha}-induced Vascular Endothelial Growth Factor Synthesis in Osteoblasts

ENHANCEMENT OF MAPK ACTIVITY*

Haruhiko Tokuda {ddagger} §, Atsushi Harada ¶, Kouseki Hirade §, Hiroyuki Matsuno §, Hidenori Ito ||, Kanefusa Kato ||, Yutaka Oiso ** and Osamu Kozawa § {ddagger}{ddagger}

From the {ddagger} Department of Internal Medicine, Chubu National Hospital, National Institute for Longevity Sciences, Obu, Aichi 474-8511, Japan, Department of Orthopaedics, Chubu National Hospital, National Institute for Longevity Sciences, Obu, Aichi 474-8511, Japan, § Department of Pharmacology, Gifu University School of Medicine, Gifu 500-8705, Japan, || Department of Biochemistry, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Aichi 480-0391, Japan, ** First Department of Internal Medicine, Nagoya University School of Medicine, Nagoya 466-8550, Japan

We have previously reported that prostaglandin F2{alpha} (PGF2{alpha}) activates p44/p42 mitogen-activated protein kinase (MAPK) through protein kinase C (PKC) in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the mechanism of vascular endothelial growth factor (VEGF) synthesis induced by PGF2{alpha} and the effect of incadronate on the VEGF synthesis in these cells. PGF2{alpha} significantly stimulated the VEGF synthesis in a dose-dependent manner between 1 pM and 10 µM. Cycloheximide reduced the PGF2{alpha} effect. PGF2{alpha} increased the levels of mRNA for VEGF. Cloprostenol, a PGF2{alpha}-sensitive receptor agonist, potently induced the VEGF synthesis. Indomethacin, an inhibitor of cyclooxygenase, significantly reduced the PGF2{alpha}-induced VEGF synthesis. Bisindolylmaleimide, an inhibitor of PKC, reduced the PGF2{alpha}-induced VEGF synthesis. The VEGF synthesis induced by PGF2{alpha} was significantly attenuated in the PKC down-regulated cells. PGF2{alpha} elicited the translocation of PKC{beta}I from cytosol to membrane fraction. PD98059 or U0126, inhibitors of MEK, suppressed the VEGF synthesis induced by PGF2{alpha}. Farnesyltransferase inhibitor failed to affect the PGF2{alpha}-induced VEGF synthesis. Incadronate enhanced the synthesis of VEGF induced by PGF2{alpha}. NaF-induced VEGF synthesis was also amplified by incadronate. PD98059 suppressed the enhancement by incadronate of PGF2{alpha}-induced VEGF synthesis. Incadronate markedly enhanced the phosphorylation of Raf-1, MEK1/2, and p44/p42 MAPK induced by PGF2{alpha} or 12-O-tetradecanoylphorbol-13-acetate, a PKC activator. Incadronate significantly enhanced the cloprostenol-increased level of VEGF concentration in mouse plasma in vivo. These results strongly suggest that PGF2{alpha} stimulates VEGF synthesis through the PKC-dependent activation of p44/p42 MAPK in osteoblasts and that the incadronate enhances the VEGF synthesis at the point between PKC and Raf-1.


Received for publication, September 6, 2002 , and in revised form, March 17, 2003.

{ddagger}{ddagger} To whom correspondence should be addressed. Tel.: 81-58-2672231; Fax: 81-58-267-2959; E-mail: okozawa{at}cc.gifu-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M.-T. Walsh, D. R. Curran, P. J. Kingham, R. K. Morgan, N. Durcan, G. J. Gleich, W. G. McLean, and R. W. Costello
Effect of Eosinophil Adhesion on Intracellular Signaling in Cholinergic Nerve Cells
Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 333 - 341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.